The impact of outpatient acute kidney injury on mortality and chronic kidney disease: a retrospective cohort study.


Journal

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
ISSN: 1460-2385
Titre abrégé: Nephrol Dial Transplant
Pays: England
ID NLM: 8706402

Informations de publication

Date de publication:
01 03 2019
Historique:
received: 25 10 2017
accepted: 29 01 2018
pubmed: 27 3 2018
medline: 28 12 2019
entrez: 27 3 2018
Statut: ppublish

Résumé

Acute kidney injury (AKI) has been extensively studied in hospital settings. Limited data exist regarding outcomes for patients with outpatient AKI who are not subsequently admitted. We investigated whether outpatient AKI, defined by a 50% increase in creatinine (Cr), is associated with increased mortality and renal events. In this retrospective study, outpatient serum Cr values from adults receiving primary care at a health system during an 18-month exposure period were used to categorize patients into one of five groups (no outpatient AKI, outpatient AKI with recovery, outpatient AKI without recovery, outpatient AKI without repeat Cr and no Cr). Principal outcomes of all-cause mortality and renal events (50% decline in estimated glomerular filtration rate to <30 mL/min/1.73 m2) were examined using Cox proportional hazards models. Among 384 869 eligible patients, 51% had at least one Cr measured during the exposure period. Outpatient AKI occurred in 1.4% of patients while hospital AKI occurred in only 0.3% of patients. The average follow-up was 5.3 years. Outpatient AKI was associated with an increased risk of all-cause mortality {adjusted hazard ratio [aHR] 1.90 [95% confidence interval (CI) 1.76-2.06]} and results were consistent across all AKI groups. Outpatient AKI was also associated with an increased risk of renal events [aHR 1.33 (95% CI 1.11-1.59)], even among those who recovered. Outpatient AKI is more prevalent than inpatient AKI and is a risk factor for all-cause mortality and renal events, even among those who recover kidney function. Further research is necessary to determine risk factors and identify strategies for preventing outpatient AKI.

Sections du résumé

BACKGROUND
Acute kidney injury (AKI) has been extensively studied in hospital settings. Limited data exist regarding outcomes for patients with outpatient AKI who are not subsequently admitted. We investigated whether outpatient AKI, defined by a 50% increase in creatinine (Cr), is associated with increased mortality and renal events.
METHODS
In this retrospective study, outpatient serum Cr values from adults receiving primary care at a health system during an 18-month exposure period were used to categorize patients into one of five groups (no outpatient AKI, outpatient AKI with recovery, outpatient AKI without recovery, outpatient AKI without repeat Cr and no Cr). Principal outcomes of all-cause mortality and renal events (50% decline in estimated glomerular filtration rate to <30 mL/min/1.73 m2) were examined using Cox proportional hazards models.
RESULTS
Among 384 869 eligible patients, 51% had at least one Cr measured during the exposure period. Outpatient AKI occurred in 1.4% of patients while hospital AKI occurred in only 0.3% of patients. The average follow-up was 5.3 years. Outpatient AKI was associated with an increased risk of all-cause mortality {adjusted hazard ratio [aHR] 1.90 [95% confidence interval (CI) 1.76-2.06]} and results were consistent across all AKI groups. Outpatient AKI was also associated with an increased risk of renal events [aHR 1.33 (95% CI 1.11-1.59)], even among those who recovered.
CONCLUSIONS
Outpatient AKI is more prevalent than inpatient AKI and is a risk factor for all-cause mortality and renal events, even among those who recover kidney function. Further research is necessary to determine risk factors and identify strategies for preventing outpatient AKI.

Identifiants

pubmed: 29579290
pii: 4951548
doi: 10.1093/ndt/gfy036
pmc: PMC6399485
doi:

Substances chimiques

Creatinine AYI8EX34EU

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

493-501

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR002494
Pays : United States

Informations de copyright

© The Author(s) 2018. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Références

Am J Kidney Dis. 1991 Feb;17(2):191-8
pubmed: 1992662
BMC Nephrol. 2014 Dec 22;15:206
pubmed: 25535396
Am J Kidney Dis. 2010 Oct;56(4):651-60
pubmed: 20673605
Am J Kidney Dis. 2016 May;67(5):742-52
pubmed: 26690912
Nephrol Dial Transplant. 2010 Jul;25(7):2203-9
pubmed: 20124548
Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1007-14
pubmed: 24677557
J Am Soc Nephrol. 2016 Mar;27(3):914-23
pubmed: 26134154
JAMA. 2005 Aug 17;294(7):813-8
pubmed: 16106006
Nephrology (Carlton). 2014 May;19(5):282-7
pubmed: 24571827
Kidney Int. 2012 Mar;81(5):477-85
pubmed: 22157656
N Engl J Med. 2017 Jan 5;376(1):11-20
pubmed: 27959707
N Engl J Med. 2004 Sep 23;351(13):1296-305
pubmed: 15385656
Kidney Int. 2007 Jul;72(2):208-12
pubmed: 17507907
Kidney Int. 2012 Dec;82(11):1208-14
pubmed: 22854642
Intensive Care Med. 2015 Aug;41(8):1411-23
pubmed: 26162677
Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2123-2131
pubmed: 27793961
Nephrol Dial Transplant. 2016 Jun;31(6):922-9
pubmed: 27190340
Kidney Int. 2016 Nov;90(5):1090-1099
pubmed: 27658322
Kidney Int Suppl (2011). 2012 Mar;2(1):19-36
pubmed: 25018918
Am J Kidney Dis. 2012 Sep;60(3):402-8
pubmed: 22541737
J Am Soc Nephrol. 2005 Nov;16(11):3365-70
pubmed: 16177006

Auteurs

Maxwell D Leither (MD)

Division of Renal Diseases and Hypertension, University of Minnesota, Minneapolis, MN, USA.

Daniel P Murphy (DP)

Division of Renal Diseases and Hypertension, University of Minnesota, Minneapolis, MN, USA.

Luke Bicknese (L)

Academic Health Center-Information Systems, University of Minnesota, Minneapolis, MN, USA.

Scott Reule (S)

Division of Renal Diseases and Hypertension, University of Minnesota, Minneapolis, MN, USA.
Section of Nephrology, Minneapolis Veterans Affairs Health Care System, Minneapolis, MN, USA.

David M Vock (DM)

Division of Biostatistics, University of Minnesota, Minneapolis, MN, USA.

Areef Ishani (A)

Division of Renal Diseases and Hypertension, University of Minnesota, Minneapolis, MN, USA.
Section of Nephrology, Minneapolis Veterans Affairs Health Care System, Minneapolis, MN, USA.

Robert N Foley (RN)

Division of Renal Diseases and Hypertension, University of Minnesota, Minneapolis, MN, USA.

Paul E Drawz (PE)

Division of Renal Diseases and Hypertension, University of Minnesota, Minneapolis, MN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH